
RXRX
USDRecursion Pharmaceuticals Inc. Class A Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$5.200
Haut
$5.320
Bas
$4.970
Volume
57.15M
Fondamentaux de l'Entreprise
Capitalisation Boursière
2.2B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
39.05M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Recursion to Participate in Upcoming Investor Conferences
Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and
Buybacks take backseat as AI drives record US capex spending
Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on.
Actions Connexes
NPFD
Nuveen Variable Rate Preferred & Income Fund Common Shares
BCGWW
Binah Capital Group Inc. Warrants
ACIU
AC Immune SA
PEG
Public Service Enterprise Group Incorporated
FLUX
Flux Power Holdings Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.